Skip to content

OptimizeRx OPRX Total debt

Total debt at other companies

Phreesia logo
PhreesiaPHR
$98.31M+242%
Doximity logo
DoximityDOCS
$10.19M-17.8%
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
$541.35M0.0%
PubMatic logo
PubMaticPUBM
$42.69M-5.8%
National Research Corporation logo
National Research CorporationNRC
$74.02M+26.2%
Veeva Systems logo
Veeva SystemsVEEV

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Calculated from OptimizeRx’s reported figures.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's total debt?
OptimizeRx (OPRX) reported total debt of $23.72M in Q1 2026.
How has OptimizeRx's total debt changed year-over-year?
OptimizeRx's total debt decreased by 27.7% year-over-year, from $32.8M to $23.72M.
What is the long-term trend for OptimizeRx's total debt?
Over 5 years (2020 to 2025), OptimizeRx's total debt has grown at a 125.4% compound annual growth rate (CAGR), from $448.75K to $26.1M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.